Determination of cystic fibrosis carrier frequency for Zuni native Americans of New Mexico

Clinical Genetics

Volumn 49, Issue 2, 1996, Pages 95-97

  Kessler, D ^a,c   Moehlenkamp, C ^b   Kaplan, G ^b  

^a Zuni PHS Hospital   (United States)

^b Integrated Genetics   (United States)

^c PHS Indian Hospital   (United States)

Author keywords

Cystic fibrosis; R1162X; Zuni native Americans

Indexed keywords

AMERICAN INDIAN; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; GENE FREQUENCY; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; UNITED STATES;

EID: 0029871709     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1996.tb04336.x     Document Type: Article

References (22)

1. Abeliovich D, Lerer I, Lavon I, Curristin S, Cutting GR. Cystic fibrosis mutations in Jewish Ashkenazi patients. Annual Meeting European Society of Human Genetics 1991: 97.
2. Balnaves ME, Nasioulas S, Dahl H-HM, Forrest S. Direct PCR from CVS and blood lysates for detection of cystic fibrosis and Duchenne muscular dystrophy deletions. NAR 1991: 19: 1155.
3. Beaudet AL, Spence JE, Montes M, O'Brien WE, Estivill X, Farrall M, Williamson R. Experience with new DNA markers for the diagnosis of cystic fibrosis. N Engl J Med 1988: 318: 50-51.
4. Bergeron P, Laberge C, Grenier A. Hereditary tyrosinemia in the province of Quebec: prevalence at birth and geographic distribution. Clin Genet 1974: 5: 157-162.
5. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th edn. New York: McGraw Hill, 1989: 2649-2680.
6. Cushing FH. Zuni. Omaha: University of Nebraska Press, 1979.
7. Disant'Agnese PA, Darling RC, Perera GA, Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas: clinical significance and relationship to the disease. Pediatrics 1953: 12: 549.
8. Ehrlich HA. PCR technology: principles and applications for DNA amplification. New York: Stockton Press, 1989: 31-37.
9. Elias S, Annas GJ, Simpson JL. Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice. Am J Obstet Gynecol 1991: 164: 1077-1083.
10. Gasparini P, Nunes V, Savoia A, Dognini M, Morral N, Gaona A, Bonizzato A, Chillon M, Sangiuolo F, Novelli G, Dallapiccola B, Pignatti PF, Estivill X. The search for South European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences. Genomics 1991: 10: 193-200.
11. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoresis. Pediatrics 1959: 23: 545-549.
12. Grebe TA, Doane WW, Richter SF, Clericuzio C, Norman RA, Seltzer WK, Rhodes SN, Goldberg BE, Hernried LS, McClure M, Kaplan G. Mutation analysis of the cystic fibrosis transmembrane regulator gene in native American populations of the Southwest. Am J Hum Genet 1992: 51: 736-740.
13. Highsmith WE, Burch LH, Boat TF, Boucher RC, Silverman LM, Knowles MR. Identification of a homozygous point mutation in intron 19 in an inbred CF patients with mild disease and normal sweat chloride: creation of an alternative splice site resulting in base-sequence insertion in CFTR coding region between exon 19 and 20. Pediatr Pulmonol Suppl 1991: 6: 22A.
14. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989: 245: 1073-1080.
15. Mercier B, Raguenes O, Estivill X, Morral N, Kaplan GC, McClure M, Grebe TA, Kessler D, Pignatti PF, Marigo C, Bombieri C, Audrezet MP, Verlingue C, Ferec C. Complete detection of mutations in cystic fibrosis patients of native American origin. Hum Genet 1994: 94: 629-632.
16. Morral N, Girvau E, Zielenski J, Nunes V, Casals T, Estivill X. Dinucleotide (CA/GT) repeat polymorphism in intron 17b of the cystic fibrosis transmembrane conductance regulator gene. Hum Genet 1992: 88: 356.
17. Morral N, Nunes V, Casals T, Estivill X. CA/GT microsatellite alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generated by unequal crossover. Genomics 1991: 10: 692-698.
18. Nunes V, Gasparini P, Novelli G, Gaona A, Bonizzato A, Sangiuolo F, Balassopoulou A, Gimenez FJ, Dognini M, Ravnik-Glavac M, CiKuli M, Mokini V, Komel R, Dallapiccola B, Pignatti PF, Loukopoulos D, Casals T, Estivill X. Analysis of 14 cystic fibrosis mutations in five South European populations. Hum Genet 1991: 87: 737-738.
19. Rodman DM, Zamudio S. The cystic fibrosis heterozygote. Advantage in surviving cholera? Medical Hypotheses 1991: 36: 253-258.
20. Wood RE, Boat TF, Doershuk CF. State of the art: cystic fibrosis. Am Rev Respir Dis 1976: 113: 833.
21. Zielenski J, Bozon D, Kerem B-S, Markiewicz D, Durie P, Rommens JM, Tsui L-C. Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991: 10: 229-235.
22. Zielenski J, Fujiwara TM, Markiewicz D, Paradis AJ, Anacleto AI, Richards B, Schwartz RH, Klinger KW, Tsui LC, Morgan K. Identification of the M1101K mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and complete detection of cystic fibrosis mutations in the Hutte-rite population. Am J Hum Genet 1993: 52: 609-615.